文献速递胃肠外科围术期管理与 ERAS

经肛微创手术治疗直肠神经内分泌肿瘤的临床经验

Transanal minimally invasive surgery for rectal neuroendocrine tumors.
PubMed 文献 · Surg Endosc · 2020-11-25

该回顾性研究纳入10例接受经肛微创手术(TAMIS)的直肠神经内分泌肿瘤(rNET)患者,肿瘤均成功切除,标本切缘全部阴性,术后无严重并发症或死亡,中位随访54个月未见复发、转移或死亡。作者认为TAMIS对小rNET安全可行,但需更多经验和临床试验明确其适应证。

要点

  • TAMIS可用于小rNET的 full-thickness 局部切除,10例均成功完成。
  • 6例原发切除均为G1,标本切缘全部阴性,4例内镜术后瘢痕切除无残留肿瘤。
  • 中位随访54个月无复发、转移或死亡,无术后严重并发症。

核心结论

  • TAMIS是小rNET安全可行的手术方式。
  • TAMIS对rNET的优劣势和适应证尚需进一步经验和临床试验明确。

研究设计与样本

  • 回顾性研究,2010年12月至2020年3月两所医院由同一腹腔镜外科医生连续实施TAMIS的25例直肠肿瘤患者中,回顾10例rNET。
  • 采用TAMIS技术完成深达外层脂肪组织的全层切除。

主要发现

  • TAMIS对小rNET全部成功完成。
  • 7例肿瘤小于10 mm,3例肿瘤在10至15 mm之间。
  • 6例原发肿瘤切除,4例内镜术后瘢痕切除。
  • 中位手术时间80.5(53-124)分钟,中位出血量1(1-12)ml。
  • 6例原发切除均为神经内分泌肿瘤G1,所有标本切缘完全阴性;4例内镜术后患者均无残留肿瘤组织学证据。

关键数值与推荐

  • 肿瘤大小:7例小于10 mm,3例在10至15 mm之间。
  • 中位手术时间80.5(53-124)分钟,中位出血量1(1-12)ml。
  • 中位术后住院7天,中位观察54个月。

临床怎么用

  • 对小rNET可考虑TAMIS行全层局部切除,以达到切缘阴性并获取完整病理分期。
  • 内镜术后瘢痕也可经TAMIS切除以排除残留肿瘤。
  • 术前应评估肿瘤大小,目前经验限于15 mm以下的小rNET。

局限性

  • 回顾性研究,仅10例rNET,样本量小。
  • 单术者、两所医院的经验,外推性有限。
  • 随访时间中位54个月,尚不足以评估远期复发。
  • 无对照组,无法与其他局部切除方式比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is no literature that mainly searched for rectal neuroendocrine tumor (rNET) using transanal minimal invasive surgery (TAMIS). We report our clinical experiences of TAMIS for rectal neuroendocrine tumors to evaluate the feasibility and safety. METHODS: Between December 2010 and March 2020, the 25 consecutive patients with rectal neoplasma underwent the TAMIS procedure performed by single laparoscopic surgeon at the two hospitals. Of these, ten patients with rectal neuroendocrine tumors were reviewed retrospectively. The full-thickness excision down to the outer fatty tissues was completed using TAMIS technique. Clinicopathological findings, perioperative and postoperative complications were recorded. RESULTS: TAMIS for small rNET was successfully completed in all cases. There were seven cases with a tumor size of less than 10 mm, and three cases with a tumor size between 10 and 15 mm. Six patients underwent the primary tumor excision; the remaining four patients underwent resection for the scar after endoscopic procedure. The median surgical duration was 80.5 (53-124) minutes and the median blood loss was 1 (1-12) ml. All removed tumors in the 6 primary excisions were diagnosed as neuroendocrine tumor G1. The margins of specimens were completely free in all cases. Among the four patients after endoscopic procedure, all had no histological evidence of residual tumor. The median length of hospital stay was 7 days postoperatively. There was no post-operative mortality or severe complication. The median length of observation was 54 months. No recurrence, no local or distant metastasis and no mortality of all patients were observed. CONCLUSIONS: TAMIS is safety and feasible procedure for small rNET. Further experience and clinical trials are needed to fully define the advantages, disadvantages, and indications of TAMIS for rNET.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Hayashi S, Takayama T, Ikarashi M, et al. Transanal minimally invasive surgery for rectal neuroendocrine tumors. Surg Endosc. 2020. PMID: 33237462. doi:10.1007/s00464-020-08178-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。